Table 4.
Antidiabetic Drug | Dose | Period | Country | Year | Authors |
---|---|---|---|---|---|
Metformin | 1000 mg | 12 weeks | India India |
2016 2017 |
Singh and Bhansali [45] Singh and Bhansali [46] |
Pioglitazone | 15–30 mg | 10–16 weeks | India India India Iran Egypt Iran |
2016 2009 2005 2019 2015 2015 |
Singh and Bhansali [45] Mittal at al. [58] Shafiq et al. [59] Ghiasi et al. [60] Hafez et al. [61] Lajevardi et al. [62] |
Rosiglitazone | 2–8 mg | 26 weeks | SUA | 2007 | Ellis et al. [63] |
Liraglutide subcutaneous injection | Initial dose: 0.6 mg—1 week 1.2 mg—1 week 1.8 mg—6 weeks |
8 weeks | Denmark | 2015 | Faurschou et al. [64] |